At Pragmatech - we are an impact driven Start-up, focusing on Cervical cancer as a domain. As our first offering, we have developed and patented India's first Self-Sampling kit that enables self-collection of cervical cells for a periodic PAP test. Additionally, we are developing a point-of-care, primary screening assay for detecting pre-cancerous cervical lesions – that can be deployed in a rural setting and can enable at-the-site treatment.
By enabling early detection and increased adoption of periodic cervical screening the impact that we are chasing is the increase in number of women who are treating their pre-cancerous lesions using simple and affordable therapies like LEEP and Cryo as opposed to cancer treatment, and eventually the YoY decrease in cervical cancer deaths.
1. Who do you think your users are?
2. Why should they adopt your solutions?
3. What is unique about your solution?